SecBot SecBot

NXGL

NEXGEL, INC.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001468929 Healthcare & Medical Devices
$3.96 −1.07 (−21.27%)
Oct 26 4:00 PM ET · prev $5.03
Market cap
$2.3M
Nano cap
Consensus
Sell
0% Buy or better · 6 analysts
Median target
$2.00
−49% · range $2.00–2.00
Next earnings
Nov 9
in 13 days · EPS est. −$4.80
1 year
−92.3%
from $51.60 · Oct 27
30 days
+11.2%
from $3.56
52-week range
$3.00–51.60
−92% from high · low Oct 8
Avg volume 20D
240.5K
Oct 14 spike 3.34M
Short interest
🔒 Subscribers only
Insider net
+$1.1M
3 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read BEARISH 4 reports · 90 days
Balance 2 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/4 ·Next Earnings date, Nov 9, 2026
Strongest NEUTRAL NEXGEL filed a Certificate of Amendment to effect a 1-for-20 reverse stock split of its common stock…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $1.1M. 1 insider sold $20.8K.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 2 trimmed or exited.

  • AnalystsBEARISH

    0 of 6 rate it Buy or better. Price is above every target.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.800 → −$4.800 over 90 days. 0 up, 1 down in 30 days.

  • TrendRANGE

    27% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
GEODE CAPITAL MANAGEMENT, LLCTRIM71,863$36.0K
HRT FINANCIAL LPDOUBLED69,485$34.0K
UBS Group AGDOUBLED24,735$12.4K
JANE STREET GROUP, LLCTRIM20,606$10.3K
GEODE CAPITAL MANAGEMENT, LLCADD128,536$81.4K
MORGAN STANLEYTRIM54,980$34.8K
JANE STREET GROUP, LLCADD42,138$26.7K
UBS Group AGDOUBLED6,634$4.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

6 analysts
Sell 0% rate it Buy or better
Strong Buy0Buy0Hold3Sell1Strong Sell2
12-month targets · 1 analysts

Price is above the highest target. Median implies −49%.Targets as of Aug 20, 2026.

Recent actions
DateFirmActionRating
Aug 24, 2026Maxim Group
DOWNGRADE
DOWNGRADEHold
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 9, 2026
Earnings date
NXGL Q3 2026 Earnings Scheduled — 2026-11-09
Recent
Oct 27, 2026
Listing
🔒 Fresh data, subscribers only
Oct 14, 2026
Trading halt
Halt Resumed: NXGL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-14T19:47:30.000Z | Resumed 2026-10-14T20:00:00.000Z
Oct 14, 2026
Trading halt
Trading Halt: NXGL — LUDP (Volatility Trading Pause)
NexGel, Inc | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Oct 14, 2026
Trading halt
Halt Resumed: NXGL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-10-14T19:35:53.000Z | Resumed 2026-10-14T19:45:53.000Z
Oct 14, 2026
Trading halt
Trading Halt: NXGL — LUDP (Volatility Trading Pause)
NexGel, Inc | Market: NASDAQ | Code: LUDP — Volatility Trading Pause

Insider ledger

Form 4
$1.1M
bought · 3 insiders
$20.8K
sold · 1 insider
DateInsiderTypeValue
Jul 23, 2026
Levy Adam R.
Chief Executive Officer
AWARD160,000 sh
Jun 23, 2026
Levy Adam R.
Chief Executive Officer
SELL$3.0K
Jun 18, 2026
Levy Adam R.
Chief Executive Officer
SELL$3.6K
Jun 11, 2026
Levy Adam R.
Chief Executive Officer
SELL$1.8K
Jun 8, 2026
Levy Adam R.
Chief Executive Officer
SELL$1.6K
Jun 4, 2026
Levy Adam R.
Chief Executive Officer
SELL$1.8K
Jun 1, 2026
Levy Adam R.
Chief Executive Officer
SELL$1.2K
May 29, 2026
Levy Adam R.
Chief Executive Officer
SELL$1.8K

Earnings setup

Estimates
Nov 9
reports in 13 days
−$4.80
EPS estimate, this quarter
−500%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$4.80-$4.80–-$4.80-500.0%$4.2M
Next Q-$4.00-$4.00–-$4.00-242.9%$5.3M
Current FY-$18.80-$18.80–-$18.80-683.3%$15.8M
Next FY-$4.40-$4.40–-$4.40-155.0%$24.3M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Oct 14, 2026Volatility PauseResumed
Oct 14, 2026Volatility PauseResumed
Oct 14, 2026Volatility PauseResumed
Oct 12, 2026Volatility PauseResumed
Oct 12, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 27, 2026 Listing status
🔒 Fresh data, subscribers only
Oct 7, 2026 SEC
NEXGEL filed a Certificate of Amendment to effect a 1-for-20 reverse stock split of its common stock, effective…
8-K — Impact 4/10
Sep 24, 2026 SEC
NexGel, Inc. filed an 8-K on September 24, 2026, disclosing that it began utilizing a new shareholder update…
8-K — Impact 3/10
Aug 20, 2026 SEC
NexGel filed an S-1 registration statement to register 15,252,337 shares of common stock for resale by selling…
S-1 — Impact 7/10
Jul 23, 2026 Insider
Levy Adam R. was granted 160,000 shares
Chief Executive Officer
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
71,863 shares ($36.0K)
Jun 30, 2026 Inst.
HRT FINANCIAL LP — DOUBLED
69,485 shares ($34.0K)
Jun 23, 2026 Insider
Levy Adam R. sold 5,000 shares
Chief Executive Officer @ $0.5933 ($3.0K)

SecBot reports

8 filings · 2 press releases · 1 bullish · 2 bearish · 5 neutral
All NXGL filing & press-release reports (10)